These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23301792)

  • 1. The precise chemical-physical nature of the pharmacore in FK506 binding protein inhibition: ElteX, a New class of nanomolar FKBP12 ligands.
    Martina MR; Tenori E; Bizzarri M; Menichetti S; Caminati G; Procacci P
    J Med Chem; 2013 Feb; 56(3):1041-51. PubMed ID: 23301792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FKBP family proteins: immunophilins with versatile biological functions.
    Kang CB; Hong Y; Dhe-Paganon S; Yoon HS
    Neurosignals; 2008; 16(4):318-25. PubMed ID: 18635947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraligand hydrophobic interactions rationalize drug affinities for peptidyl-prolyl cis-trans isomerase protein.
    Bizzarri M; Marsili S; Procacci P
    J Phys Chem B; 2011 May; 115(19):6193-201. PubMed ID: 21500789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bifunctional molecules evade cytochrome P(450) metabolism by forming protective complexes with FK506-binding protein.
    Marinec PS; Lancia JK; Gestwicki JE
    Mol Biosyst; 2008 Jun; 4(6):571-8. PubMed ID: 18493655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of calcineurin inhibition by complexes of immunosuppressive drugs with human FK506 binding proteins.
    Weiwad M; Edlich F; Kilka S; Erdmann F; Jarczowski F; Dorn M; Moutty MC; Fischer G
    Biochemistry; 2006 Dec; 45(51):15776-84. PubMed ID: 17176100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential responses of the backbone and side-chain conformational dynamics in FKBP12 upon binding the transition-state analog FK506: implications for transition-state stabilization and target protein recognition.
    Brath U; Akke M
    J Mol Biol; 2009 Mar; 387(1):233-44. PubMed ID: 19361439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptidyl-prolyl isomerase activity of FK506 binding protein 12 prevents tau peptide from aggregating.
    Ikura T; Ito N
    Protein Eng Des Sel; 2013 Sep; 26(9):539-46. PubMed ID: 23832849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and structure of non-macrocyclic inhibitors of FKBP12, the major binding protein for the immunosuppressant FK506.
    Armistead DM; Badia MC; Deininger DD; Duffy JP; Saunders JO; Tung RD; Thomson JA; DeCenzo MT; Futer O; Livingston DJ; Murcko MA; Yamashita MM; Navia MA
    Acta Crystallogr D Biol Crystallogr; 1995 Jul; 51(Pt 4):522-8. PubMed ID: 15299839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FK506-binding protein 12 ligands: a patent review.
    Liu F; Wang YQ; Meng L; Gu M; Tan RY
    Expert Opin Ther Pat; 2013 Nov; 23(11):1435-49. PubMed ID: 23957229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural characterization of the RyR1-FKBP12 interaction.
    Samsó M; Shen X; Allen PD
    J Mol Biol; 2006 Mar; 356(4):917-27. PubMed ID: 16405911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Template-based docking of a prolactin receptor proline-rich motif octapeptide to FKBP12: implications for cytokine receptor signaling.
    Soman KV; Hanks BA; Tien H; Chari MV; O'Neal KD; Morrisett JD
    Protein Sci; 1997 May; 6(5):999-1008. PubMed ID: 9144770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the FKBP.rapamycin.FRB ternary complex.
    Banaszynski LA; Liu CW; Wandless TJ
    J Am Chem Soc; 2005 Apr; 127(13):4715-21. PubMed ID: 15796538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Plasmodium falciparum FK506-binding protein (FKBP) with peptidyl-prolyl cis-trans isomerase and chaperone activities.
    Monaghan P; Bell A
    Mol Biochem Parasitol; 2005 Feb; 139(2):185-95. PubMed ID: 15664653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Large-Amplitude Breathing Motions in the Interface of FKBP12-Drug Complexes.
    Yang CJ; Takeda M; Terauchi T; Jee J; Kainosho M
    Biochemistry; 2015 Dec; 54(47):6983-95. PubMed ID: 26561008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FK506 binding protein 12 mediates sensitivity to both FK506 and rapamycin in murine mast cells.
    Fruman DA; Wood MA; Gjertson CK; Katz HR; Burakoff SJ; Bierer BE
    Eur J Immunol; 1995 Feb; 25(2):563-71. PubMed ID: 7533090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the binding sites for the interactions between FKBP12 and intracellular calcium release channels.
    Wen H; Kang S; Song Y; Song Y; Yang HJ; Kim MH; Park S
    Arch Biochem Biophys; 2012 Jan; 517(1):37-42. PubMed ID: 22100703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid protein-ligand docking using soft modes from molecular dynamics simulations to account for protein deformability: binding of FK506 to FKBP.
    Zacharias M
    Proteins; 2004 Mar; 54(4):759-67. PubMed ID: 14997571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FK506-binding protein ligands: structure-based design, synthesis, and neurotrophic/neuroprotective properties of substituted 5,5-dimethyl-2-(4-thiazolidine)carboxylates.
    Zhao L; Huang W; Liu H; Wang L; Zhong W; Xiao J; Hu Y; Li S
    J Med Chem; 2006 Jul; 49(14):4059-71. PubMed ID: 16821768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of FKBP associated protein 48 (FAP48) at proline 219 disrupts the interaction with FKBP12 and FKBP52.
    Neye H
    Regul Pept; 2001 Mar; 97(2-3):147-52. PubMed ID: 11164950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FKBP12 is the only FK506 binding protein mediating T-cell inhibition by the immunosuppressant FK506.
    Xu X; Su B; Barndt RJ; Chen H; Xin H; Yan G; Chen L; Cheng D; Heitman J; Zhuang Y; Fleischer S; Shou W
    Transplantation; 2002 Jun; 73(11):1835-8. PubMed ID: 12085010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.